Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.79 USD | -45.52% | -48.37% | +14.16% |
May. 14 | Stephens Starts Sensei Biotherapeutics With Overweight Rating, $5 Price Target | MT |
May. 09 | Sensei Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Sensei Biotherapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Sensei Biotherapeutics, Inc.
Stephens Inc. | |
HC Wainwright | |
Citigroup | |
alphavalue | Abhishek Raval |
Oppenheimer | |
Berenberg Bank | |
Piper Sandler |
EPS Revisions
- Stock Market
- Equities
- SNSE Stock
- Consensus Sensei Biotherapeutics, Inc.